{"id":"W2740393355","doi":"10.1093/annonc/mdx339","title":"Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":258,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; F. Hoffmann-La Roche; Roche","keywords":"Vemurafenib; Dacarbazine; Medicine; Confidence interval; Hazard ratio; Internal medicine; Metastatic melanoma; Progression-free survival; Melanoma; Gastroenterology; Oncology; Chemotherapy; Cancer; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008253628,0.0001383083,0.0005504427,0.0000433176,0.00008282057,0.000009352439,0.0003513139,0.00008031241,0.000005160834],"category_scores_gemma":[0.0006540362,0.0000898216,0.0001196272,0.0000376459,0.0002812531,0.000008944715,0.0001441733,0.00008718829,0.000001152792],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007260642,"about_ca_system_score_gemma":0.0001821498,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004802995,"about_ca_topic_score_gemma":0.0009027338,"domain_scores_codex":[0.9983234,0.0005846559,0.0004651765,0.0002555136,0.0001870716,0.0001841595],"domain_scores_gemma":[0.9983073,0.0001571261,0.0006972569,0.0005126448,0.0002876611,0.00003802265],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5510487,0.01158348,0.3915624,0.0001317963,0.002845347,0.0001548763,0.00488879,0.0003911623,0.01678324,0.00154848,0.002321942,0.01673984],"study_design_scores_gemma":[0.1855607,0.007584062,0.7776275,0.00003318727,0.0001085673,0.000003959158,0.0001490577,0.00001527528,0.02801112,0.0002241146,0.0005120104,0.0001703795],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946056,0.00004374517,0.00002036336,0.000338125,0.0001660713,0.0008220389,0.0001047253,0.00000170216,0.003897635],"genre_scores_gemma":[0.9994197,0.00001245961,0.0001136691,0.00009608618,0.0000310503,0.00002966798,0.00006891284,0.00001015166,0.0002182347],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3860652,"threshold_uncertainty_score":0.3662819,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04370504422132651,"score_gpt":0.3263825167606763,"score_spread":0.2826774725393497,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}